| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8824662 | Médecine Nucléaire | 2016 | 5 Pages |
Abstract
Chemoembolization and percutaneous radiofrequency are complementary treatments for hepatocellular carcinoma (CHC). Their indications are to be regularly revalued according to the evolution of the disease: the first one is indicated in multiple but limited number lesions in patients with preserved hepatic functions. The use of microparticles did not allow to obtain an advance on the long-term survival, but standardize the method. Radiofrequency is a curative treatment, with several different devices, mono- or multipolar technologies. It preserved functional hepatic tissue and has for advantage its low rate of complications in patients in a fragile state.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
A. Rode,